 At this time I would like to welcome everyone to the AMAG Pharmaceuticals First Quarter 2020 Earnings Call. Good morning and welcome to the AMAG Pharmaceuticals conference call to discuss our first quarter 2020 financial results. Please be reminded that remarks made during this call may include forward-looking statements pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. 